Abstract
Two properties of the human immunodeficiency virus (HIV) make the control of HIV spread in the human population difficult: a) infection of T cells and dendritic cells and macrophages, the professional antigen-presenting cells and b) transmission from donor to recipient by HIV-1 -infected cells. The rapid spread of HIV infection in the human population in epidemic form was enhanced by the transmission of infected cells from infected individuals to non-infected partners as part of human sexual behavior, and due to exposure of intravenous drug users to infected syringes. Despite attempts to educate the human population in safe sexual behavior, the spread of HIV infection continues and the end of the HIV epidemic is not in sight.
UNESCO European Network “Man Against Virus.”
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Becker, Y., 1993, From the discovery of poliovirus vaccinia virus mRNAs and polyribosomes to computer analysis of HIV-1 and 2 glycoproteins, in Concepts in Virology (B.W.J. Mahy and D.K. Lvov, editors) pp 77-79, Hardwood Academic Publishers.
Becker, Y, 1994a, HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses-a review, Virus Genes, 8:249–270.
Becker, Y, 1994b, An analysis of the role of skin Langerhans cells (LC) in the cytoplasmic processing of HIV-1 peptide after “peplotion” transpidermal transfer and HLA class I presentation to CD8+ CTLs-an approach to immunization of humans, Virus Genes, 9:133–147.
Becker, Y, 1995, Computer simulations to predict the availability of peptides with known HLA class I motifs possibly generated by proteolysis of HIV-1 proteins in infected cells, Virus Genes 10:in press.
Beckman, E.M., Porcelli, S.A., Morita, CT., Behar, S.M., Furlong, S., and Brenner, M.B., 1994, Recognition of a lipid antigen by CD1 restricted α/β+ T cells, Nature, 37: 691–694.
Bjorkman, P.J., Saper, M.A., Samaraoni, B., Bennet, W.S., Strominger, J.L., and Wiley, D.C., 1987, The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329:512–518, 1987.
Bolognesi, D., 1994, Not Yet, it is too early to use a live attenuated virus vaccine against HIV-1, J. NIH Res. 6:55,59-62.
Cameron, P.U., Mallal, S.A., French, M.A.H., and Dawkins, R.L. 1990, Central MHC genes between HLA-B and complement C4 confer risk for HIV-1 disease progression, Human Immunology 29:282–295.
Choi, H.K., Flynn, G.L., and Amidon, G.G., 1994, Transdermal delivery of bioactive peptides: the effect of n-decylmethyl solfoxide, pH and inhibitors of enkephalin metabolism and transport, Pharm. Res. 7:1099–1106, 1990.
Desrosiers, R.C., 1994, Yes, it is time to consider use of a live-attenuated virus vaccine against HIV, J. NIH Res. 6:54,56-59.
Haynes, B.F., 1993, Scientific and social issues of human immunodeficiency virus vaccine development, Science 260:1279–1286.
McKinney, E.L., and Streilein, J.W., 1989, On the extraordinary capacity of allogeneic epidermal Langerhans cells to prime cytotoxic T cells in vivo, J. Immunol. 143:1560–1564.
Nair, S., Babu, J.S., Dunham, R.G., Kanda, P., Burke, R.L., and Rouse, B.T., 1993, Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cells, J. Virol. 67:4062–4069.
Porcelli, S., Brenner, M.B., Greenstein, J.L., Balk, S.P., Terhorst, C. and Bleicher, P.A., 1989, Recognition of cluster of differentiation 1 antigens by human CD4−CD8− cytolytic T lymphocytes, Nature 341:447–450.
Porcelli, S., Morita, C.T., and Brenner, M.B., 1992, CD1b restricts the response of human CD4−8− T lymphocytes to a microbial antigen, Nature 360:593–597.
Rabinovich, N.R., Mclnnes, P., Klein, D.L., and Hall, B.F., 1994, Vaccine technologies: view to the future, Science 265:1401–1404.
Reid, C.D.L., Fryer, PR., Clifford, C., Kirk, A., Tikerpae, J., and Knight, S.C., 1990, Identification of hematopoietic progenitors of macrophages and dendritic Langerhans cells (DL-CFU) in human bone marrow and peripheral blood, Blood 76:1139–1149.
Sabin, A.B., 1992, Improbability of effective vaccination agaoinst human immunodeficiency virus because of its intracellular transmission and rectal portal of entry, Proc. Natl. Acad. Sci. USA 89:8852–8855.
Salk, J., Bretscher, P.A., Salk, PL., Clerici, M., and Shearer, G.M., 1993, A strategy for prophylactic vaccination against AIDS, Science 260:1270–1272.
Schultz, M., Zinkernagel, R.M., and Hengartner, H., 1991, Peptide-induced antiviral protection by cytotoxic T cells, Proc. Natl. Acad. Sci. USA 88:991–993.
Takahashi, H., Takeshita, T., Morein, B., Putney, S., Germain, R.N., and Berzofsky, J.A., 1990, Induction of CD8+ cytotoxic T cells by imunization with purified HIV-1 envelope protein in ISCOMs, Nature 34:873–875.
Walker, C., Selby, M., Erickson, A., Do, D.C., Valensi, J-P, and Van Nest, G., 1992, Cationic lipids direct a viral glycoprotein into class I major histocompatibility complex antigen-presentation pathway, Proc. Natl. Acad. Sci. USA 89:7915–7918.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Becker, Y. (1996). HIV—Peplotion Vaccine. In: Cohen, S., Shafferman, A. (eds) Novel Strategies in the Design and Production of Vaccines. Advances in Experimental Medicine and Biology, vol 397. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1382-1_14
Download citation
DOI: https://doi.org/10.1007/978-1-4899-1382-1_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-1384-5
Online ISBN: 978-1-4899-1382-1
eBook Packages: Springer Book Archive